TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
RDY

Dr. Reddy’s Laboratories Ltd

Healthcare · Drug Manufacturers - Specialty & Generic

12.50$ +2.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

Dr. Reddy’s Laboratories Ltd (RDY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 567,877 million INR. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of INR.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RDY
Line item 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
156 11,840 18,946 23,025 26,677 29,288 68,768 86,123 85,445 83,792 80,330 95,005 119,477 1,423,690 170,223 194,762 207,650 219,821 225,604 225,427 3,070 3,631 292,827 321,854 387,518 492,989 567,877
– 5,289 11,866 15,083 15,703 18,353 15,424 37,555 34,620 39,010 42,063 47,593 69,952 857,130 103,747 119,838 119,688 100,375 109,645 114,501 1,723 2,028 181,856 204,253 248,049 250,112 295,997
1.2 477 5,104 7,253 4,386 9,288 3,713 18,024 7,398 5,596 6,584 5,729 18,152 51,363 33,534 39,654 39,955 18,136 2,638 2,228 27 203 14,852 5,779 7,107 14,654 15,064
– 477 5,104 7,253 6,927 9,599 – 18,039 12,152 6,126 10,757 5,762 18,152 220,993 33,534 39,654 39,955 18,136 20,968 24,757 340 473 44,365 61,797 81,470 57,908 86,076
– 2,394 3,826 3,610 3,761 3,587 4,802 7,682 6,896 19,658 15,793 22,441 30,037 38,548 41,022 48,595 48,604 45,737 50,200 46,630 816 844 80,270 83,203 95,338 109,792 99,215
16 1,912 2,192 2,773 3,038 3,500 6,895 7,563 11,133 13,226 13,371 16,059 19,352 215,995 23,992 25,529 25,578 28,529 29,089 33,579 464 621 50,884 48,670 63,552 71,085 75,016
43 69 78 101 146 162 204 288 419 410 500 666 653 694 740 0.0 53,961 57,160 57,869 54,088 52,332 57,111 62,169 66,294 75,997 96,978 –
– 35 33 33 39 40 16,635 15,578 16,979 7,300 2,174 2,180 2,208 31,932 3,428 3,380 3,848 3,752 3,945 3,902 53 62 4,418 4,245 4,253 11,810 12,638
0.4 2,879 2,862 2,859 2,671 2,588 17,035 18,933 16,623 14,879 11,799 13,066 11,321 108,281 11,269 13,050 20,796 44,925 44,665 44,367 366 488 27,246 30,849 36,951 96,803 102,979
56 6,602 3,506 4,248 5,592 8,335 46,496 44,435 38,378 41,747 37,415 49,015 62,033 692,645 79,422 83,460 79,314 95,777 99,144 85,230 1,021 1,264 102,300 90,863 106,968 155,823 194,952
31 4,496 2,358 3,095 4,576 7,582 18,745 18,577 19,392 26,553 29,022 41,015 43,460 536,464 54,063 63,995 64,646 85,000 69,692 59,700 962 1,141 94,015 85,845 96,039 130,392 164,249
– 2,938 106 289 474 2,802 10,084 3,670 6,678 9,569 9,310 18,301 15,875 24,135 24,002 28,906 22,828 43,736 25,625 16,381 275 328 28,099 12,194 14,030 38,902 63,848
10 682 1,121 1,681 2,179 1,416 82 4,766 5,427 5,987 9,322 8,480 9,502 118,618 10,503 10,660 12,300 13,417 9,208 10,296 142 174 15,971 17,857 21,547 20,053 32,750
25 21 1.0 0.9 0.7 0.6 471 415 321 199 120 118 321 232 346 0.0 9,938 4,852 24,459 21,448 0.0 6,299 5,746 0.0 3,800 3,800 12,203
100 5,222 15,440 18,778 21,085 20,953 22,272 41,677 47,067 42,045 42,915 45,990 57,444 730,853 90,801 111,302 128,336 124,044 126,460 140,197 2,049 2,367 190,527 230,991 280,550 333,388 369,598
57 625 4,981 8,299 10,252 10,009 261 20,139 24,032 18,305 18,035 20,391 31,599 44,815 65,051 83,643 99,550 108,224 113,865 128,646 1,907 2,134 175,712 215,593 265,257 315,793 345,016
– 632 761 765 765 766 767 796 843 842 848 850 851 852 853 855 855 835 831 831 830 832 832 832 834 834 833

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?